MIM CORP
10-Q, 1999-08-16
MISC HEALTH & ALLIED SERVICES, NEC
Previous: VDI MEDIA, 10-Q, 1999-08-16
Next: AUTOBOND ACCEPTANCE CORP, 10-Q, 1999-08-16




                                    FORM 10-Q
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

(Mark One)
[X]      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended   June 30, 1999
                                 -----------------------------------------------
                                       OR
[ ]      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934
For the transition period from _________ to __________

Commission file number        0-28740
                      ----------------------------------------------------------

                                 MIM CORPORATION
             (Exact name of registrant as specified in its charter)

               Delaware                             05-0489664
- -------------------------------------   ----------------------------------------
  (State or other jurisdiction of         (I.R.S. Employer Identification No.)
   incorporation or organization)

                     100 Clearbrook Road, Elmsford, NY 10523
                  ----------------------------------------------
                    (Address of principal executive offices)

                                 (914) 460-1600
                          ------------------------------
              (Registrant's telephone number, including area code)

- -------------------------------------------------------------------------------
Former name, former address and former fiscal year if changed since last report)


    Indicate by  check mark  whether the  registrant  (1) has filed all  reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days.

Yes  [X]   No  [ ]


                      APPLICABLE ONLY TO CORPORATE ISSUERS:

    On   August  3,  1999,  there  were  outstanding  18,729,189  shares  of the
Company's common stock, $.0001 par value per share ("Common Stock").


<PAGE>

                                      INDEX
<TABLE>
<CAPTION>
                                                                                              Page Number
                                                                                              -----------
<S>   <C>           <C>                                                                           <C>
PART I              FINANCIAL INFORMATION

      Item 1        Financial Statements

                    Consolidated Balance Sheets at
                         June 30, 1999 (unaudited) and December 31, 1998                           3

                    Unaudited Consolidated Statements of Operations for the
                         three months and six months ended June 30, 1999 and 1998                  4

                    Unaudited Consolidated Statements of Cash Flows for the
                         six months ended June 30, 1999 and 1998                                   5

                    Notes to the Consolidated Financial Statements                                6-8

      Item 2        Management's Discussion and Analysis of Financial Condition
                    and Results of Operations                                                     9-18

      Item 3        Quantitative and Qualitative Disclosures about Market Risk                     19

PART II             OTHER INFORMATION

      Item 1        Legal Proceedings                                                            20-21

      Item 2        Changes in Securities and Use of Proceeds                                      21

      Item 4        Submission of Matters to a Vote of Security Holders                            21

      Item 5        Other Information                                                              21

      Item 6        Exhibits and Reports on Form 8-K                                               21

      SIGNATURES                                                                                   22

      Exhibit Index                                                                                23
</TABLE>


                                       2
<PAGE>

                                     PART 1
                              FINANCIAL INFORMATION
Item 1. Financial Statements

                        MIM CORPORATION AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS
                      (In thousands, except share amounts)
<TABLE>
<CAPTION>
<S>                                                                                       <C>                 <C>
                                                                                          June 30,            December 31,
                                                                                            1999                  1998
                                                                                     -------------------   -------------------
                                                                                        (Unaudited)
ASSETS
Current assets
      Cash and cash equivalents                                                                 $ 6,316               $ 4,495
      Investment securities                                                                       5,373                11,694
      Receivables, less allowance for doubtful accounts of $2,123 and $2,239
           at June 30, 1999 and December 31, 1998, respectively                                  60,759                64,747
      Inventory                                                                                     860                 1,187
      Prepaid expenses and other current assets                                                     877                   857
                                                                                     -------------------   -------------------
             Total current assets                                                                74,185                82,980

Other investments                                                                                 2,317                 2,311
Property and equipment, net                                                                       6,608                 4,823
Due from affiliate and officer, less allowance for doubtful accounts of $403
           at June 30, 1999 and December 31, 1998, respectively                                   1,804                    34
Other assets, net                                                                                   161                   293
Deferred income taxes                                                                               274                   270
Intangible assets, net                                                                           18,950                19,395
                                                                                     -------------------   -------------------
             Total assets                                                                     $ 104,299             $ 110,106
                                                                                     ===================   ===================

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
      Current portion of capital lease obligations                                                $ 494                 $ 277
      Current portion of long-term debt                                                             362                   208
      Accounts payable                                                                            5,769                 6,926
      Claims payable                                                                             33,296                32,855
      Payables to plan sponsors and others                                                       15,832                16,490
      Accrued expenses                                                                            5,435                 6,401
                                                                                     -------------------   -------------------
             Total current liabilities                                                           61,188                63,157

Capital lease obligations, net of current portion                                                   986                   598
Long-term  debt, net of current portion                                                             723                 6,185

Commitments and contingencies
Minority interest                                                                                 1,112                 1,112

Stockholders' equity
      Preferred stock, $.0001 par value; 5,000,000 shares authorized,
           no shares issued or outstanding                                                           -                     -
      Common stock, $.0001 par value; 40,000,000 shares authorized,
           18,729,198 and 18,090,748 shares issued and outstanding
           at June 30, 1999 and December 31, 1998, respectively                                       2                     2
      Treasury stock at cost                                                                       (338)                    -
      Additional paid-in capital                                                                 91,614                91,603
      Accumulated deficit                                                                       (49,449)              (50,790)
      Stockholder notes receivable                                                               (1,539)               (1,761)
                                                                                     -------------------   -------------------
             Total stockholders' equity                                                          40,290                39,054
                                                                                     -------------------   -------------------

             Total liabilities and stockholders' equity                                       $ 104,299             $ 110,106
                                                                                     ===================   ===================

The accompanying notes are an integral part of these consolidated financial statements.
</TABLE>


                                       3
<PAGE>


<TABLE>
<CAPTION>

                                                  MIM CORPORATION AND SUBSIDIARIES
                                                CONSOLIDATED STATEMENTS OF OPERATIONS
                                              (In thousands, except per share amounts)


                                                               Three months ended                   Six months ended
                                                                     June 30,                            June 30,
                                                            -------------------------         ----------------------------
                                                               1999             1998              1999              1998
                                                            -------------------------         ----------------------------
                                                                 (Unaudited)                           (Unaudited)
<S>                                                         <C>              <C>               <C>               <C>

Revenue                                                     $  88,894        $ 109,878         $ 163,809         $ 207,841

Cost of revenue                                                81,077          103,660           147,810           196,044
                                                            -----------      -----------       -----------       ----------
         Gross profit                                           7,817            6,218            15,999            11,797

Selling, general and administrative expenses                    7,074            4,811            14,586             9,261
Amortization of goodwill and other intangibles                    194               --               444                 --
                                                            -----------      -----------       -----------       ----------

         Income from operations                                   549            1,407               969             2,536

Interest income, net                                              188              483               384               990
Other                                                              --               (1)              (12)               (1)
                                                            -----------      -----------       -----------       ----------

Net income                                                  $     737        $   1,889         $   1,341         $   3,525
                                                            ===========      ===========       ===========       ==========




Basic income per common share                               $    0.04        $    0.14         $    0.07         $    0.26
                                                            ===========      ===========       ===========       ==========

Diluted income per common share                             $    0.04        $    0.12         $    0.07         $    0.23
                                                            ===========      ===========       ===========       ==========

Weighted average common shares used
         in computing basic income per share                   18,777           13,594            18,639             13,471
                                                            ===========      ===========       ===========       ==========
Weighted average common shares used
         in computing diluted income per share                 18,953           15,489            18,883             15,467
                                                            ===========      ===========       ===========       ==========


The accompanying notes are an integral part of these consolidated financial statements.


</TABLE>


                              4


<PAGE>


<TABLE>
<CAPTION>


                                                  MIM CORPORATION AND SUBSIDIARIES
                                               CONSOLIDATED STATEMENTS OF CASH FLOWS
                                                           (In thousands)

                                                                                                              Six Months Ended
                                                                                                                   June 30,
                                                                                                         ---------------------------
                                                                                                            1999             1998
                                                                                                         ------------    -----------
<S>                                                                                                       <C>              <C>
Cash flows from operating activities:                                                                            (Unaudited)
         Net income                                                                                       $  1,341         $  3,525
                  Adjustments to reconcile net income to net cash provided
                       by (used in) operating activities:
                        Depreciation, amortization and other                                                 1,181              722
                       Stock option charges                                                                      6               14
                       Provision for losses on receivables                                                    --               --
                       Provision for losses on receivables and due from affiliates                            --                 53
         Changes in assets and liabilities:
                  Receivables                                                                                3,988          (17,392)
                  Inventory                                                                                    327             --
                  Prepaid expenses and other current assets                                                    (20)            (334)
                  Accounts payable                                                                          (1,157)             111
                  Deferred revenue                                                                            --             (2,799)
                  Claims payable                                                                               441            4,850
                  Payables to plan sponsors and others                                                        (658)           2,234
                  Accrued expenses                                                                            (970)           1,826
                                                                                                         ------------    -----------
                       Net cash provided by (used in) operating activities                                   4,479           (7,190)
                                                                                                         ------------    -----------

Cash flows from investing activities:
                  Purchase of property and equipment                                                        (1,592)          (1,051)
                  Loans to affiliate and officer, net                                                       (1,770)            --
                  Stockholder loans, net                                                                       222              (23)
                  Purchase of investment securities                                                         (1,013)         (16,855)
                  Maturities of investment securities                                                        7,334           18,425
                  Investment in preferred stock                                                               --               --
                  Decrease (increase) in other assets                                                          130             (211)
                                                                                                         ------------    -----------
                       Net cash provided by  investing activities                                            3,311              285
                                                                                                         ------------    -----------

Cash flows from financing activities:
                  Principal payments on capital lease obligations                                             (328)            (108)
                  Net payments on debt                                                                      (5,308)            --
                  Proceeds from exercise of stock options                                                        5                3
                  Purchase of treasury stock                                                                  (338)            --
                                                                                                         ------------    -----------
                       Net cash used in financing activities                                                (5,969)            (105)
                                                                                                         ------------    -----------
Net decrease in cash and cash equivalents                                                                    1,821           (7,010)

Cash and cash equivalents--beginning of period                                                            $  4,495         $  9,593
                                                                                                         ------------    -----------
Cash and cash equivalents--end of period                                                                  $  6,316         $  2,583
                                                                                                         ============    ===========
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
         Cash paid during the period for:
                  Interest                                                                                $     86         $     37
                                                                                                         ============    ===========
SUPPLEMENTAL DISCLOSURE OF NONCASH TRANSACTIONS:
         Equipment acquired under capital lease obligations                                               $    933               $-
                                                                                                         ============    ===========


The accompanying notes are an integral part of these consolidated financial statements.
</TABLE>


                                       5
<PAGE>


                        MIM CORPORATION AND SUBSIDIARIES
            NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                    (In thousands, except per share amounts)

NOTE 1 - BASIS OF PRESENTATION

     The accompanying unaudited consolidated interim financial statements of MIM
Corporation and subsidiaries  (the "Company") have been prepared pursuant to the
rules and  regulations  of the U.S.  Securities  and  Exchange  Commission  (the
"Commission").  Pursuant to such rules and regulations,  certain information and
footnote  disclosures  normally  included in  financial  statements  prepared in
accordance with generally accepted accounting  principles have been condensed or
omitted. In the opinion of management,  all adjustments considered necessary for
a fair presentation of the financial statements,  primarily consisting of normal
recurring  adjustments,  have been included.  The results of operations and cash
flows for the six months ended June 30, 1999 are not  necessarily  indicative of
the results of  operations or cash flows which may be reported for the remainder
of 1999.

     These  unaudited  consolidated  financial  statements  should  be  read  in
conjunction with the Company's audited consolidated financial statements,  notes
and  information  included in the  Company's  Annual Report on Form 10-K for the
fiscal year ended December 31, 1998 filed with the Commission (the "Form 10-K").

     The accounting  policies followed for interim  financial  reporting are the
same as  those  disclosed  in Note 2 to the  consolidated  financial  statements
included in the Form 10-K.

NOTE 2 - EARNINGS PER SHARE

     The following  table sets forth the computation of basic earnings per share
and diluted earnings per share:
<TABLE>
<CAPTION>



                                                  Three Months                      Six Months
                                                 Ended June 30,                   Ended June 30,
<S>                                            <C>              <C>             <C>             <C>
                                               1999             1998            1999            1998
                                             --------         --------        --------        --------
Numerator:
- ---------
  Net income                                $   737         $ 1,889         $ 1,341         $ 3,525
                                            =======         =======         =======         =======

Denominator:
- ------------
 Weighted average number of
    common shares outstanding                18,777          13,594          18,639          13,471
                                            -------         -------         -------         -------
Basic Earnings per Share                    $   .04         $   .14         $   .07         $   .26
                                            =======         =======         =======         =======

Denominator:
- ------------
  Weighted average number of
    common shares outstanding                18,777          13,594          18,639          13,471
  Common share equivalents
    of outstanding stock options                176           1,895             194           1,996
                                            -------         -------         -------         -------
Total shares outstanding                     18,953          15,489          18,833          15,467
                                            -------         -------         -------         -------
Diluted Earnings per Share                  $   .04         $   .12         $   .07         $   .23
                                            =======         =======         =======         =======
</TABLE>


NOTE 3 - ACQUISITION

     On August 24, 1998,  the Company  completed its  acquisition of Continental
Managed   Pharmacy   Services,   Inc.   and  its   subsidiaries   (collectively,
"Continental"),  a company which provides pharmacy benefit  management  services
and mail order pharmacy services.  The acquisition was treated as a purchase for
financial reporting purposes. The Company issued 3,912 shares of Common Stock as
consideration for the purchase. The aggregate purchase price, including costs of
acquisition of $1,100, approximated


                                       6
<PAGE>


$19,100. The fair value of assets acquired  approximated $11,100 and liabilities
assumed approximated $11,800, resulting in approximately $18,300 of goodwill and
$1,200 of other  intangible  assets which will be amortized over their estimated
useful lives (25 years for goodwill  and six and four years,  respectively,  for
other intangibles). The consolidated financial statements of the Company for the
three  and six  month  periods  ended  June 30,  1999  include  the  results  of
Continental.

     The  following  unaudited  consolidated  pro  forma  information  has  been
prepared assuming Continental was acquired as of January 1, 1998, with pro forma
adjustments for amortization of goodwill and other intangible  assets and income
taxes. The pro forma  information is presented for  informational  purposes only
and is not  indicative of what would have occurred if the  acquisition  had been
made on January 1, 1998. In addition, this pro forma information is not intended
to be a projection of future operating results.

                                           Six months ended June 30,

                                              1999               1998
                                              ----               ----

Revenue                                  $     163,809        $   238,605
                                         =============        ===========

Net income                               $       1,341        $     4,400
                                         =============        ===========

Basic earnings per share                 $         .07        $       .25
                                         =============        ===========

Diluted earnings per share               $         .07        $       .23
                                         =============        ===========

The amounts above include  $29,770 of revenue from the operations of Continental
for the six months ended June 30, 1999 and $30,764 for the six months ended June
30, 1998.

NOTE 4 - COMMITMENTS AND CONTINGENCIES

     On March  31,  1999,  the  State of  Tennessee  and  Xantus  Healthplan  of
Tennessee,  Inc. ("Xantus") entered into a consent decree under which Xantus was
placed  in  receivership  under  the  laws  of  the  State  of  Tennessee.   The
Commissioner of the Tennessee Department of Commerce and Insurance,  as receiver
of  Xantus,  is  currently  preparing  a report to  determine  whether a plan of
rehabilitation  or liquidation is advisable,  based on, among other things,  the
ability  of Xantus  to pay its  post-petition  obligations  to  providers,  plan
members  and other  creditors.  At this time,  the  Company is unable to predict
whether the receiver will recommend rehabilitation or liquidation or the effects
of these actions or the  implementation  of either plan on the Company's ability
to collect  monies  owed to it by Xantus.  As of July 1, 1999,  Xantus  owed the
Company $10,800 for pharmacy benefit management ("PBM") services rendered by the
Company  from  January 1, 1999 through  April 1, 1999,  approximately  $4,600 of
which the Company has withheld  from its pharmacy  providers as permitted by the
Company's agreements with these pharmacy providers. State of Tennessee officials
have publicly  indicated that the State will ensure that all TennCare  providers
negatively  impacted  by  the  appointment  of  the  receiver  for  Xantus  will
eventually  receive  from  Xantus or the  State at least 50% of all  outstanding
amounts  owed by Xantus to such  providers  as of April 1,  1999,  although  the
Company can give no assurance  that Xantus or the State will  eventually pay any
or all of these  amounts.  The failure of the Company to collect  from Xantus or
the State all or a substantial  portion of the monies owed to it by Xantus would
have a material adverse effect on the Company's  financial condition and results
of operations.

NOTE 5 - LOAN TO OFFICER

     In April  1999,  the Company  loaned to the  Chairman  and Chief  Executive
Officer of the Company  $1,700,  evidenced  by a  promissory  note  secured by a
pledge  of 1,500  shares  of the  Company's  Common  Stock.  The  note  requires
repayment of principal and interest by March 31, 2004.  Interest accrues monthly
at the Prime Rate (as defined in the note) then in effect. The loan was approved
by the  Company's  Board of Directors  in order to provide  funds with which the
Chairman  could pay the  Federal  and state tax  liability


                                       7
<PAGE>


associated with the exercise of stock options  representing  1,500 shares of the
Company's Common Stock in January 1998.

NOTE 6 - CONTRACTS

     As part of the Company's normal review process, the Company determined that
each of the Company's agreements (collectively, the "Agreements") with Tennessee
Health Partnership  ("THP") and Preferred Health Partnership of Tennessee,  Inc.
("PHP") were not achieving profitability projections.  Accordingly, in the first
quarter of 1999, in  accordance  with the terms of the  Agreements,  the Company
exercised its right to terminate the Agreements effective on September 28, 1999.

     On June 25, 1999, the Company notified both THP and PHP that it would cease
providing  PBM  services  to them  and  their  members  if past due  amounts  of
approximately  $500 and $540  were not paid  within 30 days as  required  by the
Agreements.  On July 23, 1999, THP and PHP filed complaints in the United States
District Court for the Eastern  District of Tennessee  alleging that the Company
did not have the right to cease  providing  services under the  Agreements.  The
complaints  also  alleged  that THP and PHP  disputed  the  outstanding  amounts
invoiced by the Company under the  Agreements and demanded that such disputes be
arbitrated as required under the Agreements.  Additionally,  THP and PHP applied
for a  temporary  restraining  order  as well  as a  preliminary  and  permanent
injunction to prevent the Company from ceasing to provide PBM services until the
conclusion of such arbitration proceedings.

      The  hearing  on the  motion  for  the  temporary  restraining  order  was
scheduled to be heard on Wednesday,  August 4, 1999. However, on Tuesday, August
3, 1999, the Company, THP and PHP agreed that (i) the Company would withdraw its
termination  notices which were to become effective September 28, 1999; (ii) the
Agreements  would be extended  until  December 31, 1999 under a  fee-for-service
(rather a than capitated) arrangement effective October 1, 1999 through December
31, 1999; (iii) the parties would negotiate diligently and in good faith towards
the  execution by October 1, 1999 of a new two-year  arrangement  for the period
January 1, 2000 through December 31, 2001 (collectively, "New Agreements"); (iv)
THP and PHP would dismiss the complaints without  prejudice,  subject to sharing
or  arbitration  as  described  below;  and (v) in the  event  that the  parties
successfully  negotiate the New Agreements by October 1, 1999, the parties would
share  equally  all  disputed  amounts;  in the event  that the  parties  cannot
successfully  negotiate  New  Agreements  by October 1, 1999,  the parties would
submit all disputed  amounts and issues to  arbitration  in accordance  with the
arbitration  provisions  of the  Agreements.  While the  parties  have agreed to
negotiate  the terms of a new two-year  arrangement,  no assurance  can be given
that the Company will be able to successfully  renegotiate contracts with either
or both of THP and PHP.  The Company  does not  believe  that its  inability  to
renegotiate successfully contracts with either or both of THP and PHP would have
a material adverse effect on its results of operations or financial condition.


                                     * * * *


                                       8
<PAGE>


Item 2.  Management's Discussion and Analysis of Financial
         Condition and Results of Operations

     The following  discussion and analysis  should be read in conjunction  with
the   Consolidated   Financial   Statements,   the  related  notes  thereto  and
Management's  Discussion  and  Analysis of  Financial  Condition  and Results of
Operations  included in the Company's  Annual Report on Form 10-K for the fiscal
year  ended  December  31,  1998 (the  "Form  10-K"),  as well as the  unaudited
consolidated interim financial statements and the related notes thereto included
in Part I, Item 1 of this  Quarterly  Report on Form 10-Q for the fiscal quarter
ended June 30, 1999 filed with the Commission (this "Report").

    This  Report  contains  statements  not purely  historical  and which may be
considered  forward looking  statements within the meaning of Section 27A of the
Securities Act of 1933, as amended (the  "Securities  Act"),  and Section 21E of
the Securities Exchange Act of 1934, as amended (the "Exchange Act"),  including
statements regarding the Company's expectations,  hopes, beliefs,  intentions or
strategies  regarding  the  future.   Forward  looking  statements  may  include
statements relating to the Company's business development activities,  sales and
marketing efforts, the status of material contractual arrangements including the
negotiation or re-negotiation of such arrangements, future capital expenditures,
the effects of regulation  and  competition  on the Company's  business,  future
operating  performance  of the Company and the  results,  the benefits and risks
associated  with  integration  of  acquired  companies,  the effect of year 2000
problems  on the  Company's  operations,  the  effect  of legal  proceedings  or
investigations  on the  Company  and its  business  and  operations  and/or  the
resolution or settlement thereof.  Investors are cautioned that any such forward
looking  statements are not guarantees of future  performance  and involve risks
and  uncertainties,  and that actual results may differ materially from those in
the forward  looking  statements as a result of various  factors.  These factors
include,  among other things,  risks  associated  with risk-based or "capitated"
contracts,  increased  government  regulation  related  to the  health  care and
insurance  industries  in  general  and  more  specifically,   pharmacy  benefit
management organizations,  increased competition from the Company's competitors,
including  competitors with greater  financial,  technical,  marketing and other
resources,  and the  existence of complex laws and  regulations  relating to the
Company's  business.  This Report  along with the  Company's  Form 10-K  contain
information  regarding important factors that could cause such differences.  The
Company does not undertake any obligation to publicly release the results of any
revisions to these forward  looking  statements  that may be made to reflect any
future events and circumstances.

Overview

     The  Company is an  independent  pharmacy  benefit  management  ("PBM") and
prescription   mail  service   organization  that  partners  with  managed  care
organizations and healthcare  providers to endeavor to control prescription drug
costs. A majority of the Company's revenues have been derived from providing PBM
services  in the State of  Tennessee  to managed  care  organizations  ("MCO's")
participating in the State of Tennessee's TennCare program and behavioral health
organizations  ("BHO's")  participating  in the  State of  Tennessee's  TennCare
Partners  program.  At June 30, 1999,  the Company  provided PBM services to 157
health plan  sponsors  with an  aggregate  of  approximately  2.0  million  plan
members,  of which TennCare  represented 7 health plans with  approximately  1.2
million  plan  members.  The  TennCare  contracts  accounted  for  51.1%  of the
Company's  revenues  for the six  months  ended  June 30,  1999 and 74.2% of the
Company's  revenues for the six months ended June 30, 1998. With the addition of
another  TennCare  MCO  as  of  May  1,  1999,  the  Company   anticipates  that
approximately 48% of its revenues for fiscal 1999 will be derived from providing
PBM services to the TennCare MCO's.

                                       9
<PAGE>

Results of Operations

Three months ended June 30, 1999 compared to three months ended June 30, 1998

     For the three months ended June 30, 1999, the Company  recorded  revenue of
$88.9 million compared with revenue of $109.9 million for the three months ended
June 30, 1998, a decrease of $21.0  million.  Contracts  with TennCare  sponsors
accounted for decreased  revenues of $31.6 million as the Company did not retain
contracts  as of  January  1, 1999  with the two  TennCare  BHO's it  previously
managed under a contract (the "RxCare Contract") with RxCare of Tennessee,  Inc.
("RxCare"),  which  expired on December  31, 1998,  and did not begin  providing
services to another  TennCare MCO previously  managed under the RxCare  Contract
until May 1, 1999. See "Other  Matters" below for a more detailed  discussion of
the Company's  past  relationship  with RxCare and the  expiration of the RxCare
Contract. The loss of these contracts represents $29.1 million and $5.7 million,
respectively, of the decrease in revenue, partially offset by increases in other
contracts  with TennCare  sponsors of  approximately  $3.2  million.  Commercial
revenue increased $6.1 million,  offset by a decrease of $9.8 million due to the
loss of a contract with a Nevada-based managed care organization, representing a
net decrease of $3.7 million in  commercial  revenue.  This overall  decrease in
revenues was  partially  offset by an increase in revenues of $14.3 million as a
result  of the  Company's  acquisition  in  August  1998  of the  operations  of
Continental Managed Pharmacy Services Inc. ("Continental").

    For the three months ended June 30, 1999, approximately 31% of the Company's
revenues were generated from capitated  contracts  compared to 35% for the three
months ended June 30, 1998, a decrease of 4%. This  decrease  resulted  from the
Company not  providing  PBM services  until May 1, 1999 to a major  TennCare MCO
previously  managed  on a  capitated  basis  throughout  1998  under the  RxCare
Contract,  as well as the addition of new  fee-for-service PBM business together
with the Company's acquisition of Continental.

     Cost of revenue for the three months ended June 30, 1999 decreased to $81.1
million from $103.7 million for the three months ended June 30, 1998, a decrease
of $22.6 million.  Contracts with TennCare sponsors  accounted for $26.9 million
of such  decrease as the Company did not retain  contracts as of January 1, 1999
with the two TennCare BHO's it previously  managed under the RxCare Contract and
did not begin  providing  services to another  TennCare MCO  previously  managed
under  the  RxCare  Contract  until  May 1,  1999.  The loss of these  contracts
represents  $27.1  million  and $5.0  million,  respectively,  of the  decrease,
partially  offset by  increases in other  contracts  with  TennCare  sponsors of
approximately  $5.2  million.  Cost of revenue  increases  of $3.2  million from
commercial  business  were  offset by a  decrease  in cost of  revenue  of $10.4
million  due  to  the  loss  of a  contract  with a  Nevada-based  managed  care
organization,  representing  a net decrease of $7.2 million.  Such  decreases in
cost of revenue were  partially  offset by increases in cost of revenue of $11.5
million resulting from the Company's acquisition of Continental. As a percentage
of revenue,  cost of revenue  decreased to 91.2% for the three months ended June
30,  1999 from 94.3% for the three  months  ended June 30,  1998,  a decrease of
3.1%. This decrease resulted  primarily due to the contribution of Continental's
mail service drug  distribution  business  which has  experienced  better profit
margins than historically experienced by the Company's PBM business.

     Selling,  general and  administrative  expenses  were $7.1  million for the
three months  ended June 30, 1999  compared to $4.8 million for the three months
ended June 30, 1998, an increase of $2.3 million. The acquisition of Continental
accounted  for the entire  $2.3  million of the  increase.  As a  percentage  of
revenue,  selling, general and administrative expenses increased to 8.0% for the
three  months  ended June 30, 1999 from 4.4% for the three months ended June 30,
1998,  an  increase  of  3.6%,  primarily   attributable  to  revenue  decreases
experienced  from  the loss of  certain  contracts  with  TennCare  sponsors  as
discussed above.

     For the three months ended June 30, 1999, the Company recorded amortization
of goodwill and other  intangibles of $0.2 million compared with no amortization
expense for the three months ended June 30, 1998,  an increase of $0.2  million.
This  amortization  expense  relates  soley  to  the  Company's  acquisition  of
Continental.   The  Continental   acquisition   resulted  in  the  recording  of
approximately  $18.6  million of goodwill and $1.2  million of other  intangible
assets,  which will be amortized over their estimated useful lives (25 years for
goodwill and six years and four years for other intangible assets).

For the three months ended June 30, 1999, the Company recorded  interest income,
net of  interest  expense,  of $.2 million  compared  to interest  income of $.5
million for the three  months  ended June 30,  1998,  a decrease of $.3 million.
This  decrease in interest  income  resulted  from a reduced level of investment
opportunities  due to the additional  working capital needs of the Company.  See
"Liquidity and Capital Resources."

                                       10
<PAGE>


     For the three months ended June 30, 1999,  the Company  recorded net income
of $.7  million,  or $.04 per  diluted  share as  compared to net income of $1.9
million, or $.12 per diluted share, for the three months ended June 30, 1998.


Six months ended June 30, 1999 compared to six months ended June 30, 1998

     For the six months ended June 30,  1999,  the Company  recorded  revenue of
$163.8 million  compared with revenue of $207.8 million for the six months ended
June 30, 1998, a decrease of $44.0  million.  Contracts  with TennCare  sponsors
accounted for decreased  revenues of $70.5 million as the Company did not retain
contracts  as of  January  1, 1999  with the two  TennCare  BHO's it  previously
managed  under the RxCare  Contract and did not begin  providing PBM services to
another  TennCare MCO previously  managed under the RxCare Contract until May 1,
1999. The loss of these  contracts  represents  $52.7 million and $23.3 million,
respectively, of the decrease in revenue, partially offset by increases in other
contracts  with TennCare  sponsors of  approximately  $5.5  million.  Commercial
revenue  increased  $15.0 million,  offset by a decrease of $18.3 million due to
the  loss  of a  contract  with  a  Nevada-  based  managed  care  organization,
representing a net decrease of $3.3 million in commercial  revenue.  The overall
decrease in revenues  was  partially  offset by an increase in revenues of $29.8
million as a result of the Company's acquisition of Continental.

     For the six months ended June 30, 1999,  approximately 38% of the Company's
revenues were  generated from  capitated  contracts  compared to 37% for the six
months  ended June 30,  1998,  an increase of 1%. This  increase  resulted  from
changes in arrangements  with the TennCare MCO's in 1999 as compared to 1998. As
of January 1, 1999,  the Company began  providing  capitated PBM services to two
major MCO's previously managed on a fee-for-service  basis throughout 1998 under
the RxCare Contract. In addition,  the Company did not begin providing capitated
PBM services to another MCO until May 1, 1999, which MCO was previously  managed
on a capitated basis throughout 1998 under the RxCare Contract. The Company also
acquired  other  non-risk  PBM business  through the  Company's  acquisition  of
Continental.

     Cost of revenue for the six months ended June 30, 1999  decreased to $147.8
million  from $196.0  million for the six months ended June 30, 1998, a decrease
of $48.2 million.  Contracts with TennCare sponsors  accounted for $63.3 million
of such  decrease as the Company did not retain  contracts as of January 1, 1999
with the two TennCare BHO's it previously  managed under the RxCare Contract and
did not begin providing PBM services to another TennCare MCO previously  managed
under  the  RxCare  Contract  until  May 1,  1999.  The loss of these  contracts
represents  $49.3  million and $21.2  million,  respectively,  of the  decrease,
partially  offset by  increases in other  contracts  with  TennCare  sponsors of
approximately  $7.2  million.  Cost of revenue  increases of $12.9  million from
commercial  business  were  offset by a  decrease  in cost of  revenue  of $21.8
million  due  to  the  loss  of a  contract  with a  Nevada-based  managed  care
organization,  representing  a net decrease of $8.9 million.  Such  decreases in
cost of revenue were partially  offset by increases of $24.0 million as a result
of the Company's acquisition of Continental. As a percentage of revenue, cost of
revenue decreased to 90.2% for the six months ended June 30, 1999 from 94.3% for
the six months ended June 30, 1998, a decrease of 4.1%.  This decrease  resulted
primarily  due  to  the   contribution  of   Continental's   mail  service  drug
distribution   business  which  has  experienced   better  profit  margins  than
historically experienced by the Company's PBM business.

     Selling, general and administrative expenses were $14.6 million for the six
months  ended June 30, 1999  compared to $9.3  million for the six months  ended
June 30, 1998,  an increase of $5.3  million.  The  acquisition  of  Continental
accounted for $4.7 million of the increase.  The remaining $.6 million  increase
in expenses  reflects  expenditures  incurred in  connection  with the Company's
continuing  commitment  to enhance  its ability to manage  efficiently  pharmacy
benefits  by  investing  in  information  systems  to support  new and  existing
customers.  As a  percentage  of revenue,  selling,  general and  administrative
expenses  increased to 8.9% for the six months ended June 30, 1999 from 4.5% for
the six months ended June 30, 1998, an increase of 4.4%, primarily  attributable
to  revenue  decreases  experienced  from the  loss of  certain  contracts  with
TennCare sponsors as discussed above.

                                       11
<PAGE>


     For the six months ended June 30, 1999, the Company  recorded  amortization
of goodwill and other  intangibles of $0.4 million compared with no amortization
expense for the six months  ended June 30,  1998,  an increase of $0.4  million.
This  amortization  expense  relates  solely  to the  Company's  acquisition  of
Continental.   The  Continental   acquisition   resulted  in  the  recording  of
approximately  $18.6  million of goodwill and $1.2  million of other  intangible
assets,  which will be amortized over their estimated useful lives (25 years for
goodwill and six years and four years for other intangible assets).

     For the six months  ended June 30,  1999,  the  Company  recorded  interest
income, net of interest expense,  of $0.4 million compared to interest income of
$1.0 million for the six months ended June 30, 1998, a decrease of $0.6 million.
This  decrease  in interest  income  resulted  from a reduced  level of invested
capital  due to the  additional  working  capital  needs  of  the  Company.  See
"Liquidity and Capital Resources."

     For the six months ended June 30, 1999, the Company  recorded net income of
$1.3 million,  or $.07 per diluted share compared to net income of $3.5 million,
or $.23 per diluted share, for the six months ended June 30, 1998.

Liquidity and Capital Resources

    The Company utilizes both funds generated from operations, if any, and funds
raised in its initial public offering (the "Offering") for capital  expenditures
and working  capital  needs.  For the six months ended June 30,  1999,  net cash
provided  from  operating  activities  totaled  $4.5  million,  due  mainly to a
decrease  in  accounts  receivable  of $3.9  million  resulting  primarily  from
improved collections of accounts receivable and a proportionate  decrease in PBM
business.

     Investing  activities  generated  $3.3 million  primarily  from proceeds of
maturities  of investment  securities  of $7.3  million.  This cash provided was
partially  offset by purchases  of $1.6  million of  equipment  and a loan to an
officer of $1.7 million.  The  equipment  purchases are primarily to upgrade and
enhance  information  systems  necessary to strengthen and support the Company's
ability to manage its  customer's  PBM programs and to be competitive in the PBM
industry.  The loan to an officer  enabled the Chairman to pay Federal and state
tax  liabilities  associated  with  the  exercise  of stock  options.  Financing
activities  used $6.0  million  of cash  primarily  to  decrease  the  Company's
revolving debt by $5.3 million.

     At June 30, 1999, the Company had working capital of $13.0 million compared
to $19.8 million at December 31, 1998, a decrease of $6.8 million. Cash and cash
equivalents  increased  to $6.3  million  at June 30,  1999  compared  with $4.5
million at December  31,  1998,  an increase  of $1.8  million.  The Company had
investment securities held to maturity of $5.4 million at June 30, 1999 compared
with $11.7  million at  December  31,  1998,  a decrease  of $6.3  million.  The
decrease in investment  securities  was due to the Company's  increased  working
capital requirements. With the exception of the Company's $2.3 million preferred
stock  investment in Wang Healthcare  Information  Systems,  Inc., the Company's
investments  are  primarily  corporate  debt  securities  rated AA or higher and
government securities.

     On March  31,  1999,  the  State of  Tennessee  and  Xantus  Healthplan  of
Tennessee,  Inc. ("Xantus") entered into a consent decree under which Xantus was
placed  in  receivership  under  the  laws  of  the  State  of  Tennessee.   The
Commissioner of the Tennessee Department of Commerce and Insurance,  as receiver
of  Xantus,  is  currently  preparing  a report to  determine  whether a plan of
rehabilitation  or liquidation is advisable,  based on, among other things,  the
ability  of Xantus  to pay its  post-petition  obligations  to  providers,  plan
members  and other  creditors.  At this time,  the  Company is unable to predict
whether the receiver will recommend rehabilitation or liquidation or the effects
of these actions or the  implementation  of either plan on the Company's ability
to collect  monies  owed to it by Xantus.  As of July 1, 1999,  Xantus  owed the
Company $10.8  million for PBM services  rendered by the Company from January 1,
1999 through April 1, 1999,  approximately $4.6 million of which the Company has
withheld from its pharmacy  providers as permitted by the  Company's  agreements
with these  pharmacy  providers.  State of  Tennessee  officials  have  publicly
indicated  that the State will ensure  that all  TennCare  providers  negatively
impacted by the appointment of the receiver for Xantus will  eventually  receive
from Xantus or the State at least 50% of all outstanding  amounts owed by Xantus
to such  providers  as of  April  1,  1999,  although  the  Company  can give no
assurance  that  Xantus or the  State  will  eventually  pay any or all of these
amounts. The failure of the Company to collect from Xantus or the State all or a
substantial  portion  of the monies  owed to it by Xantus  would have a material
adverse effect on the Company's financial condition and results of operations.



                                       12
<PAGE>

     In April  1999,  the Company  loaned to the  Chairman  and Chief  Executive
Officer of the Company $1.7 million, evidenced by a promissory note secured by a
pledge of 1.5 million  shares of the Company's  Common Stock.  The note requires
repayment of principal and interest by March 31, 2004.  Interest accrues monthly
at the Prime Rate (as defined in the note) then in effect. The loan was approved
by the  Company's  Board of Directors  in order to provide  funds with which the
Chairman  could pay the  Federal  and state tax  liability  associated  with the
exercise  of stock  options  representing  1.5 million  shares of the  Company's
Common Stock in January 1998.

     As part of the Company's normal review process, the Company determined that
each of the Company's agreements (collectively, the "Agreements") with Tennessee
Health Partnership  ("THP") and Preferred Health Partnership of Tennessee,  Inc.
("PHP") were not achieving profitability projections.  Accordingly, in the first
quarter of 1999, in  accordance  with the terms of the  Agreements,  the Company
exercised its right to terminate the Agreements effective on September 28, 1999.

     On June 25, 1999, the Company notified both THP and PHP that it would cease
providing  PBM  services  to them  and  their  members  if past due  amounts  of
approximately  $500,000 and $540,000 were not paid within 30 days as required by
the  Agreements.  On July 23, 1999,  THP and PHP filed  complaints in the United
States  District Court for the Eastern  District of Tennessee  alleging that the
Company did not have the right to cease providing services under the Agreements.
The complaints  also alleged that THP and PHP disputed the  outstanding  amounts
invoiced by the Company under the  Agreements and demanded that such disputes be
arbitrated as required under the Agreements.  Additionally,  THP and PHP applied
for a  temporary  restraining  order  as well  as a  preliminary  and  permanent
injunction to prevent the Company from ceasing to provide PBM services until the
conclusion of such arbitration proceedings.

      The  hearing  on the  motion  for  the  temporary  restraining  order  was
scheduled to be heard on Wednesday,  August 4, 1999. However, on Tuesday, August
3, 1999, the Company, THP and PHP agreed that (i) the Company would withdraw its
termination  notices which were to become effective September 28, 1999; (ii) the
Agreements  would be extended  until  December 31, 1999 under a  fee-for-service
(rather a than capitated) arrangement effective October 1, 1999 through December
31, 1999; (iii) the parties would negotiate diligently and in good faith towards
the  execution by October 1, 1999 of a new two-year  arrangement  for the period
January 1, 2000 through December 31, 2001 (collectively, "New Agreements"); (iv)
THP and PHP would dismiss the complaints without  prejudice,  subject to sharing
or  arbitration  as  described  below;  and (v) in the  event  that the  parties
successfully  negotiate the New Agreements by October 1, 1999, the parties would
share  equally  all  disputed  amounts;  in the event  that the  parties  cannot
successfully  negotiate  New  Agreements  by October 1, 1999,  the parties would
submit all disputed  amounts and issues to  arbitration  in accordance  with the
arbitration  provisions  of the  Agreements.  While the  parties  have agreed to
negotiate  the terms of a new two-year  arrangement,  no assurance  can be given
that the Company will be able to renegotiate  successfully contracts with either
or both of THP and PHP.  The Company  does not  believe  that its  inability  to
renegotiate successfully contracts with either or both of THP and PHP would have
a material adverse effect on its results of operations or financial condition.

      Under Section 145 of the Delaware General  Corporation Law ("Section 145")
and the  Company's  Amended and  Restated  By-Laws  ("By-Laws"),  the Company is
obligated to indemnify two former  officers of the Company (one of which is also
a former director and still a principal  stockholder of the Company) who are the
subject of the  indictments  brought in the United States District Court for the
Western District of Tennessee (as more fully described in the Form 10-K), unless
it is  ultimately  determined  by the  Company's  Board of Directors  that these
former  officers  failed to act in good  faith and in a manner  they  reasonably
believed to be in the best  interests  of the  Company,  that they had reason to
believe  that their  conduct was  unlawful of for any other  reason  under which
indemnification  would not be required Section 145 or the By-Laws.  In addition,
until the Board makes such a determination,  the Company is also obligated under
Section  145 and its  By-Laws to advance  the costs of defense to such  persons;
however,  if the Board  determines  that either or both of these former officers
are not  entitled to  indemnification,  such  individuals  would be obligated to
reimburse the Company for all amounts so advanced.  The Company is not presently
in a  position  to assess the  likelihood  that  either or both of these  former
officers will be entitled to such  indemnification and continued  advancement of
defense  costs  or to  estimate  the  total  amount  that it may  have to pay in
connection with such obligations or the time period over which such amounts will
have to be advanced.  No assurance  can be given,  however,  that the  Company's
obligations to either or both of these former officers would not have a material
adverse effect on the Company's results of operations or financial condition.



                                       13
<PAGE>

    At  December  31,  1998,  the  Company  had,  for tax  purposes,  unused net
operating loss ("NOL")  carryforwards  of  approximately  $47 million which will
begin expiring in 2008. As it is uncertain  whether the Company will realize the
full benefit from these NOL carryforwards,  the Company has recorded a valuation
allowance  equal to the deferred tax asset generated by the  carryforwards.  The
Company assesses the need for a valuation  allowance at each balance sheet date.
The  Company has  undergone  a "change in  control"  as defined in the  Internal
Revenue  Code of 1986,  as  amended  ("Code"),  and the  rules  and  regulations
promulgated thereunder.  The amount of NOL carryforwards that may be utilized in
any given year will be subject to a limitation  as a result of this change.  The
annual limitation approximates $2.7 million. Actual utilization in any year will
vary based on the Company's tax position in that year.

    As the Company  continues to grow, it anticipates  that its working  capital
needs will also continue to increase. The Company expects to spend approximately
$1.7 million on capital  expenditures  during fiscal 1999 ($0.7 million of which
was expended  through the second  quarter of 1999)  primarily  for expansion and
continued  upgrading of information  systems.  The Company  believes that it has
sufficient cash on hand or available to fund the Company's  anticipated  working
capital and other cash needs for at least the next twelve months.

    The  Company  may  also  pursue   joint   venture   arrangements,   business
acquisitions  and other  strategic  transactions  and  arrangements  designed to
expand its business, which the Company would expect to fund from cash on hand or
future  indebtedness  or,  if  appropriate,  the  sale  or  exchange  of  equity
securities of the Company.

Other Matters

    From January 1994 through  December 31, 1998,  the Company  provided a broad
range of PBM services with respect to RxCare's  TennCare,  TennCare Partners and
commercial PBM business under the RxCare Contract. Under the terms of the RxCare
Contract,  the Company performed  essentially all of RxCare's  obligations under
its PBM  contracts  with plan  sponsors,  including  designing and marketing PBM
programs  and  services.  Under the RxCare  Contract,  the Company  paid certain
amounts to RxCare and  shared  with  RxCare the  profit,  if any,  derived  from
services performed under RxCare's contracts with the plan sponsors.

    The Company and RxCare did not renew the RxCare  Contract  which  expired on
December 31, 1998. The negotiated termination of the Company's relationship with
RxCare, among other things,  allowed the Company to market directly its services
to Tennessee  customers,  including  those MCO's and  commercial  customers then
serviced by the Company  through the RxCare  Contract,  prior to its expiration.
The RxCare Contract had previously prohibited the Company from soliciting and/or
marketing  its PBM  services in  Tennessee  other than on behalf of, and for the
benefit of,  RxCare.  See  "Management's  Discussion  and  Analysis of Financial
Condition and Results of Operations -- Overview" in the Company's  Annual Report
on Form 10-K for the fiscal year ended  December  31,  1998 for a more  detailed
discussion of the Company's past  relationship with RxCare and the expiration of
the RxCare Contract.



                                       14
<PAGE>

     The Company's pharmaceutical claims costs historically have been subject to
significant increases from October through February,  which the Company believes
is due to the need for increased  medical  attention to, and intervention  with,
MCO's members during the colder months. The resulting increase in pharmaceutical
costs  impacts the  profitability  of capitated  contracts  or other  risk-based
arrangements. Risk-based business represented approximately 38% of the Company's
revenues  while  non-risk  business  (including  the  provision  of  mail  order
services)  represented  approximately 62% of the Company's  revenues for the six
months ended June 30, 1999. Non-risk arrangements mitigate the adverse effect on
profitability   of  higher   pharmaceutical   costs  incurred  under  risk-based
contracts.  The Company  presently  anticipates  that  approximately  31% of its
revenues in fiscal 1999 will be derived from risk-based arrangements.

     Changes in prices charged by manufacturers  and wholesalers or distributors
for  pharmaceuticals,  a component of pharmaceutical  claims,  have historically
affected the Company's cost of revenue.  The Company  believes that it is likely
that prices will continue to increase  which could have an adverse effect on the
Company's gross profit.  To the extent such cost increases  adversely effect the
Company's gross profit,  the Company may be required to increase  contract rates
on new contracts and upon renewal of existing contracts.  However,  there can be
no  assurance  that the  Company  will be  successful  in  obtaining  these rate
increases.  The higher level of non-risk contracts with the Company's  customers
in 1999  compared  to  prior  years  mitigates  the  adverse  effects  of  price
increases,  although no  assurance  can be given that the recent  trend  towards
non-risk arrangements will continue.

    Generally,  loss  contracts  arise  only on  capitated  or other  risk-based
contracts and primarily  result from higher than expected  pharmacy  utilization
rates,  higher than  expected  inflation in drug costs and the  inability of the
Company to restrict its MCO clients'  formularies  to the extent  anticipated by
the  Company  at the time  contracted  PBM  services  are  implemented,  thereby
resulting  in higher  than  expected  drug  costs.  At such  time as  management
estimates  that a contract will sustain  losses over its  remaining  contractual
life, a reserve is established for these estimated  losses.  Management does not
believe that there is an overall trend towards losses on its existing  capitated
contracts.

Year 2000 disclosure

     The  so-called  "year  2000  problem,"  which is common to many  companies,
concerns the inability of information  systems,  primarily computer hardware and
software programs,  to recognize properly and process date sensitive information
following  December  31,  1999.  The  Company  committed  substantial  resources
(approximately  $2.6 million) during 1997 and 1998 and  anticipates  spending an
additional  $1.7  million  during 1999 to improve its  information  systems ("IS
project").  The Company has used this IS project as an  opportunity  to evaluate
its state of readiness,  estimate expected costs and identify and quantify risks
associated with any potential year 2000 issues.


                                       15
<PAGE>


State of Readiness:
- ------------------

     In evaluating  the Company's  potential  exposure to the year 2000 problem,
management  first  identified  those  systems that were  critical to the ongoing
business of the Company and that would require  significant manual  intervention
should those systems be unable to process dates correctly following December 31,
1999. Those systems were the Company's claims adjudication and processing system
and the internal accounting system (which includes pharmacy reimbursement). Once
those systems were identified, the following steps were identified as those that
would be required to be taken to ascertain the Company's state of readiness:

I.       Obtaining  letters from software and  hardware  vendors  concerning the
         ability of their products to properly  process dates after December 31,
         1999;
II.      Testing the operating  systems of all hardware  used in the  identified
         information  systems to determine if dates after  December 31, 1999 can
         be processed correctly;
III.     Surveying   other  parties  who  provide  or  process   information  in
         electronic  format to the  Company as to their state of  readiness  and
         ability to process dates after December 31, 1999; and
IV.      Testing the  identified  information  systems to confirm that they will
         properly recognize and process dates after December 31, 1999.

     The Company  (excluding  for  purposes of this year 2000  discussion  only,
Continental)  has completed  Step I. The Company will continue to obtain letters
from  new  hardware  and  software  vendors.   The  Company  has  completed  the
implementation of Step II. All server/host  operating systems have been upgraded
to  manufacturer  specifications  to be year 2000  compliant.  The Company  will
continue  to  monitor  software   manufacturer  patch  releases  for  additional
enhancements.

     With respect to Step III above, the Company has engaged in discussions with
the third party vendors that transmit data from member pharmacies and based upon
such discussions it believes that such third party vendors' systems will be able
to properly  recognize  and process dates after  December 31, 1999.  The Company
continues  surveying  member  pharmacies  in its network as to their  ability to
transmit data  correctly to such third party vendors.  Questionnaires  have been
distributed to all member pharmacies.  Follow-up letters recently have been sent
to all pharmacies that have not responded.  With respect to the pharmacies which
have responded,  based upon such responses, the Company does not anticipate that
any additional steps will be required to allow such pharmacies to process claims
transactions  through the third party vendors after  December 31, 1999.  For the
remaining  pharmacies,  once this survey is complete,  the Company will evaluate
any additional steps required to allow member  pharmacies to transmit data after
December 31, 1999 and will disclose  such  additional  steps,  if any, and their
related costs in future periodic reports.

     With respect to Step IV above,  the Company  successfully  completed a year
2000 compliance test of the claims  adjudication  and processing  systems during
our regularly  scheduled  disaster recovery drill,  which took place on June 28,
1999.  As a result of this  compliance  test,  the Company  believes  its claims
adjudication and processing  system will be able to properly accept and transmit
data after  December  31, 1999 with no  significant  disruption.  The  Company's
internal  accounting  and  other  administrative  systems  generally  have  been
internally developed during the last few years or are presently being developed.
Accordingly,  in light of the fact that such systems were  developed with a view
to year 2000  compliance,  the Company  fully expects that these systems will be
able to properly recognize and process dates after December 31, 1999.

    Continental's  computer  systems  related to the delivery of  pharmaceutical
products  through  mail order  were  upgraded  in the fourth  quarter of 1998 to
become year 2000  compliant.  Continental's  internal  accounting  systems  were
upgraded during the second quarter of 1999, and are now year 2000 compliant. All
remaining  systems at Continental  are on schedule to be compliant by the end of
the third quarter of 1999.


                                       16
<PAGE>


Costs:
- -----

     As noted above,  the Company spent  approximately  $2.6 million during 1997
and  1998  to  improve  its  information  systems.  In  addition,   the  Company
anticipates that it will spend approximately $1.7 million (of which $0.7 million
was expended in the first six months of 1999) during 1999 to further improve its
information  systems.  These  improvements  were not,  and are not  intended  to
specifically  address the year 2000 issue,  but rather to address other business
needs and issues.  Nonetheless,  the IS project has  provided the Company with a
platform from which to address any year 2000 issues. Management does not believe
that the amount of funds  expended in connection  with the IS project would have
differed materially in the absence of the year 2000 problem.  The Company's cash
on hand as a result of the Offering  has  provided all of the funds  expended to
date on the IS project and is expected to provide substantially all of the funds
expected to be spent during 1999 on the IS project.

Risks:
- -----

     On July 29, 1998, the Commission issued Release No. 33-7558 (the "Release")
in an effort to provide  further  guidance  to  reporting  companies  concerning
disclosure of the year 2000  problem.  In this Release the  Commission  required
that registrants  include in its year 2000 disclosure a description of its "most
reasonably  likely worst case scenario."  Based on the Company's  assessment and
the results of  remediation  performed to date as described  above,  the Company
believes  that all  problems  related  to the year 2000 will be  addressed  in a
timely manner so that the Company will experience little or no disruption in its
business  immediately  following  December  31,  1999.  However,  if  unforeseen
difficulties arise, if the Company's further assessment of Continental  uncovers
significant  problems  (which is not presently  expected to occur) or if further
compliance  testing  is  delayed  or  necessary   remediation  efforts  are  not
accomplished in accordance with the Company's plans described above, the Company
anticipates that its "most  reasonably  likely worst case scenario" (as required
to be described by the Release) is that some percentage of the Company's  claims
would need to be processed  manually for some  limited  period of time,  because
member  pharmacies  would not be able to transmit data  electronically.  At this
point in time, the Company cannot  reasonably  estimate the number of pharmacies
or the level of claims  involved  or the costs  that  would be  incurred  if the
Company  were  required  to hire  temporary  staff and incur  other  expenses to
manually process such claims.  The Company expects to be better able to quantify
the number of  pharmacies  and level of claims  involved  as well as the related
costs  following its completion of the survey of member  pharmacies in the third
quarter of 1999 and  presently  intends to  disclose  such  estimates  in future
periodic  reports.  In addition,  the Company  anticipates  that all  businesses
(regardless of their state of readiness),  including the Company, will encounter
some minimal level of disruption in its business  (e.g.,  phone and fax systems,
alarm systems, etc.) as a result of the year 2000 problem.  However, the Company
does not believe that it will incur any material expenses or suffer any material
loss of revenues in connection with such minimal disruptions.

Contingency Plans:
- -----------------

     As discussed  above, in the event of the occurrence of the "most reasonably
likely  worst case  scenario"  the Company  would hire an  appropriate  level of
temporary staff to manually  process the pharmacy claims  submitted on paper. As
discussed above, at this time the Company cannot reasonably  estimate the number
of pharmacies or level of claims involved or the costs that would be incurred if
the Company were required to hire  temporary  staff and incur other  expenses to
manually process such claims. While some level of manual processing is common in
the industry and while manual processing increases the time it takes the Company
to pay the member  pharmacies and invoice the related  payers,  the Company does
not foresee any material lost revenues or other material  expenses in connection
with this  scenario.  However,  an extended delay in processing  claims,  making
payments to pharmacies  and billing the  Company's  customers  could  materially
adversely impact the Company's liquidity.

     In  addition,  while not part of the "most  reasonably  likely  worst  case
scenario," the delay in paying such  pharmacies for their claims could result in
adverse relations between the Company and the pharmacies. Such adverse relations
could cause certain  pharmacies to drop out of the Company's  networks  which in
turn could cause the Company to be in breach under service area provisions under
certain of its  services


                                       17
<PAGE>

agreements  with its  customers.  The Company does not believe that any material
relationship  with any pharmacy will be so affected or that any material  number
of pharmacies would withdraw from the Company's  networks or that it will breach
any  such  service  area   provision  of  any  contract   with  its   customers.
Notwithstanding the foregoing,  based upon past experience, the Company believes
that it could quickly replace any such withdrawing pharmacy so as to prevent any
breach of any such provision.  The Company cannot presently  reasonably estimate
the possible impact in terms of lost revenues, additional expenses or litigation
damages or expenses that could result from such events.

Forward Looking Statements:
- --------------------------

     Certain information set forth above regarding the year 2000 problem and the
Company's plans to address those problems are forward looking  statements  under
the  Securities   Act  and  the  Exchange  Act.  See  the  first   paragraph  in
"Management's  Discussion  and  Analysis of Financial  Condition  and Results of
Operations" for a discussion of forward looking statements and related risks and
uncertainties.  In addition, certain factors particular to the year 2000 problem
could cause  actual  results to differ  materially  from those  contained in the
forward looking statements,  including, without limitation:  failure to identify
critical information systems which experience failures, delays and errors in the
compliance and remediation  efforts described above,  unexpected failures by key
vendors,  member pharmacies,  software providers or business partners to be year
2000 compliant or the inability to repair  critical  information  systems in the
time  frames  described  above.  In any such  event,  the  Company's  results of
operations and financial condition could be materially  adversely  affected.  In
addition,  the failure to be year 2000 compliant of third parties outside of the
Company's  control such as electric  utilities or financial  institutions  could
adversely effect the Company's results of operations and financial condition.


                                     * * * *

                                       18
<PAGE>


Item 3.  Quantitative and Qualitative Disclosures About Market Risk

     The Company  believes that interest  rate risk  represents  the only market
risk exposure applicable to the Company.  The Company's exposure to market risks
associated  with changes in interest  rates  relates  primarily to the Company's
investments in marketable  securities in accordance with the Company's corporate
investment  policies and guidelines.  All of these instruments are classified as
"held-to-maturity" on the Company's consolidated balance sheets and were entered
into by the Company solely for investment purposes and not for trading purposes.
The  Company  does  not  invest  in  or  otherwise  use   derivative   financial
instruments.  The  Company's  investments  consist  primarily of corporate  debt
securities,   corporate   preferred  stock  and  State  and  local  governmental
obligations,  each rated AA or higher.  The table below presents  principal cash
flow amounts and related weighted average  effective  interest rates by expected
(contractual)  maturity dates for the Company's financial instruments subject to
interest rate risk:
<TABLE>

                                    1999          2000           2001        2002      2003    Thereafter
                                    ----          ----           ----        ----      ----    ----------
<CAPTION>
<S>                                <C>              <C>            <C>         <C>       <C>           <C>

Short-term investments
  Fixed rate investments           5,350            --             --           -         -            --
  Weighted average rate            6.68%            --             --           -         -            --

Long-term investments:
  Fixed rate investments              --            --             --           -         -            --
  Weighted average rate               --            --             --           -         -            --

Long-term debt:
  Variable rate instruments           91           312            682           -         -            --
  Weighted average rate            9.00%         9.00%          7.83%           -         -            --


</TABLE>


    In the  table  above,  the  weighted  average  interest  rate for  fixed and
variable  rate  financial  instruments  in each year was computed  utilizing the
effective  interest rate at June 30, 1999 for that instrument  multiplied by the
percentage  obtained by dividing the  principal  payments  expected in that year
with respect to that  instrument by the aggregate  expected  principal  payments
with respect to all financial instruments within the same class of instrument.

   At June 30, 1999, the carrying values of cash and cash equivalents,  accounts
receivable,  accounts payable,  claims payable and payables to plan sponsors and
others approximate fair value due to their short-term nature.

    Because  management  does not believe  that its  exposure  to interest  rate
market  risk is  material  at this  time,  the  Company  has  not  developed  or
implemented  a strategy to manage this market risk through the use of derivative
financial instruments or otherwise.  The Company will assess the significance of
interest  rate  market  risk from time to time and will  develop  and  implement
strategies to manage that risk as appropriate.


                                     * * * *


                                       19
<PAGE>


                                     PART II
                                OTHER INFORMATION

Item 1.  Legal Proceedings

     On March 31, 1999, the State of Tennessee and Xantus entered into a consent
decree under which Xantus was placed in receivership under the laws of the State
of  Tennessee.  The  Commissioner  of the  Tennessee  Department of Commerce and
Insurance,  as receiver of Xantus, is currently  preparing a report to determine
whether a plan of  rehabilitation  or liquidation is advisable,  based on, among
other  things,  the ability of Xantus to pay its  post-petition  obligations  to
providers, plan members and other creditors. At this time, the Company is unable
to predict whether the receiver will recommend  rehabilitation or liquidation or
the  effects  of these  actions  or the  implementation  of  either  plan on the
Company's  ability to collect  monies owed to it by Xantus.  As of July 1, 1999,
Xantus owed the Company $10.8  million for PBM services  rendered by the Company
from January 1, 1999 through April 1, 1999,  approximately $4.6 million of which
the Company  has  withheld  from its  pharmacy  providers  as  permitted  by the
Company's agreements with these pharmacy providers. State of Tennessee officials
have publicly  indicated that the State will ensure that all TennCare  providers
negatively  impacted  by  the  appointment  of  the  receiver  for  Xantus  will
eventually  receive  from  Xantus or the  State at least 50% of all  outstanding
amounts  owed by Xantus to such  providers  as of April 1,  1999,  although  the
Company can give no assurance  that Xantus or the State will  eventually pay any
or all of these  amounts.  The failure of the Company to collect  from Xantus or
the State all or a substantial  portion of the monies owed to it by Xantus would
have a material adverse effect on the Company's  financial condition and results
of operations.

     As part of the Company's normal review process, the Company determined that
its Agreements  with THP and PHP were not achieving  profitability  projections.
Accordingly,  in the first quarter of 1999, in accordance  with the terms of the
Agreements,  the  Company  exercised  its  right  to  terminate  the  Agreements
effective on September 28, 1999.

     On June 25, 199, the Company  notified both THP and PHP that it would cease
providing  PBM  services  to them  and  their  members  if past due  amounts  of
approximately  $500,000 and $540,000 were not paid within 30 days as required by
the  Agreements  with those  organizations.  On July 23, 1999, THP and PHP filed
complaints  in the United  States  District  Court for the  Eastern  District of
Tennessee  alleging  that the Company did not have the right to cease  providing
services  under the  Agreements.  The  complaints  also alleged that THP and PHP
disputed the  outstanding  amounts  invoiced by the Company under the Agreements
and demanded that such disputes be arbitrated as required under the  Agreements.
Additionally, THP and PHP applied for a temporary restraining order as well as a
preliminary  and  permanent  injunction  to prevent the Company  from ceasing to
provide PBM services until the conclusion of such arbitration proceedings.

      The  hearing  on the  motion  for  the  temporary  restraining  order  was
scheduled to be heard on Wednesday,  August 4, 1999. However, on Tuesday, August
3, 1999, the Company, THP and PHP agreed that (i) the Company would withdraw its
termination  notices which were to become effective September 28, 1999; (ii) the
Agreements  would be extended  until  December 31, 1999 under a  fee-for-service
(rather a than capitated) arrangement effective October 1, 1999 through December
31, 1999; (iii) the parties would negotiate diligently and in good faith towards
the  execution by October 1, 1999 of a new two-year  arrangement  for the period
January 1, 2000 through December 31, 2001 (collectively, "New Agreements"); (iv)
THP and PHP would dismiss the complaints without  prejudice,  subject to sharing
or  arbitration  as  described  below;  and (v) in the  event  that the  parties
successfully  negotiate the New Agreements by October 1, 1999, the parties would
share  equally  all  disputed  amounts;  in the event  that the  parties  cannot
successfully  negotiate  New  Agreements  by October 1, 1999,  the parties would
submit all disputed  amounts and issues to  arbitration  in accordance  with the
arbitration  provisions  of the  Agreements.  While the  parties  have agreed to
negotiate  the terms of a new two-year  arrangement,  no assurance  can be given
that the Company will be able to renegotiate  successfully contracts with either
or both of THP and PHP.  The


                                       20
<PAGE>


Company  does  not  believe  that  its  inability  to  renegotiate  successfully
contracts  with  either or both of THP and PHP  would  have a  material  adverse
effect on its results of operations or financial condition.

Item 2.  Changes in Securities and Use of Proceeds

     From August 14, 1996 through March 31, 1999, the  $46,788,000  net proceeds
from the initial public  offering (the  "Offering"),  pursuant to a Registration
Statement  assigned  file  number  333-05327  by  the  Securities  and  Exchange
Commission  and declared  effective by the  Commission on August 14, 1996,  have
been applied in the following approximate amounts:

         Construction of plant, building and facilities..............$         -
         Purchase and installation of machinery and equipment........$ 5,860,000
         Purchases of real estate....................................$         -
         Acquisition of other business...............................$ 2,341,000
         Repayment of indebtedness...................................$         -
         Working capital.............................................$26,898,000
         Temporary investments:
              Marketable securities..................................$ 5,373,000
              Overnight cash deposits................................$ 6,316,000

    To date, the Company has expended a relatively  insignificant portion of the
Offering proceeds on expansion of the Company's  "preferred  generics"  business
which was  described  more fully in the Offering  prospectus  and the  Company's
Annual Report on Form 10-K for the year ended  December 31, 1996. At the time of
the Offering,  however,  as disclosed in the Offering  prospectus and subsequent
Forms SR, the Company intended to apply  approximately $18.6 million of Offering
proceeds to fund an expansion of the "preferred  generics" program.  The Company
has  determined  not to apply any material  portion of the Offering  proceeds to
fund any expansion of this  program.  The Company  presently  intends to use the
remaining  Offering proceeds to support the continued growth of its PBM and mail
order business.

Item 4.  Submission of Matters to a Vote of Security Holders

     No matters  were  submitted  to a vote of the  Company's  security  holders
during the second quarter of fiscal 1999.

Item 5.  Other Information

     None.

Item 6.  Exhibits and Reports on Form 8-K

(a) Exhibits

         Exhibit Number                     Description
         --------------                     -----------

              27                            Financial Data Schedule


(b) Reports on Form 8-K

     The Company did not file any reports on Form 8-K during the second  quarter
of fiscal 1999.


                                       21
<PAGE>


SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  Report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                            MIM CORPORATION




Date: August 13, 1999                                /s/ Edward J. Sitar
                                            ------------------------------------
                                                   Edward J. Sitar
                                                   Chief Financial Officer
                                                   (Principal Financial Officer)


                                       22
<PAGE>


                                  Exhibit Index
         (Exhibits being filed with this Quarterly Report on Form 10-Q)


27       Financial Data Schedule


                                       23

<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                                 DEC-31-1999
<PERIOD-START>                                     JAN-1-1999
<PERIOD-END>                                      JUN-30-1999
<CASH>                                                  6,316
<SECURITIES>                                            5,373
<RECEIVABLES>                                          62,882
<ALLOWANCES>                                            2,123
<INVENTORY>                                               860
<CURRENT-ASSETS>                                       74,185
<PP&E>                                                 10,287
<DEPRECIATION>                                          3,679
<TOTAL-ASSETS>                                        104,299
<CURRENT-LIABILITIES>                                  61,188
<BONDS>                                                     0
                                       0
                                                 0
<COMMON>                                                    2
<OTHER-SE>                                             40,288
<TOTAL-LIABILITY-AND-EQUITY>                          104,299
<SALES>                                               163,809
<TOTAL-REVENUES>                                      163,809
<CGS>                                                 147,810
<TOTAL-COSTS>                                         147,810
<OTHER-EXPENSES>                                            0
<LOSS-PROVISION>                                            0
<INTEREST-EXPENSE>                                          0
<INCOME-PRETAX>                                         1,341
<INCOME-TAX>                                                0
<INCOME-CONTINUING>                                     1,341
<DISCONTINUED>                                              0
<EXTRAORDINARY>                                             0
<CHANGES>                                                   0
<NET-INCOME>                                            1,341
<EPS-BASIC>                                            0.07
<EPS-DILUTED>                                            0.07



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission